← Browse by Condition
Medical Condition
locally advanced melanoma
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2, Phase 1
NCT05269381 Phase 1, Phase 2
Recruiting
Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
Enrollment
132 pts
Location
United States
Sponsor
Mayo Clinic
NCT06066138 Phase 1
Recruiting
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Enrollment
30 pts
Location
United States
Sponsor
National Cancer Institute (NCI...